Evidence map›Paper›PMID 20919648›Full record

ReviewAdvances in experimental medicine and biology2010

Ceramide in stress response.

Mariana N Nikolova-Karakashian, Krassimira A Rozenova

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 127 citations in OpenAlex.

  1. Function ofInsects · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Sphingolipid signaling in kidney diseases.American journal of physiology. Renal physiology · 2025
    Review
  7. Article
  8. Article
  9. AKT2Signal transduction and targeted therapy · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Ceramides and Acute Kidney Injury.Seminars in nephrology · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mariana N Nikolova-KarakashianDepartment of Physiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA. mnikolo@uky.edu
Krassimira A Rozenova
University of Kentucky · US

Funding

The Interaction of Interleukin 1b and Glucocorticoid Signaling Pathways in Alzheimer's DiseaseR01AG019223 · NIA · UNIVERSITY OF KENTUCKY · PI NIKOLOVA-KARAKASHIAN, MARIANA N · 2002 to 2022
$5.1M
Role of Neutral Sphingomyelinase-2 in agingR01AG026711 · NIA · UNIVERSITY OF KENTUCKY · PI NIKOLOVA-KARAKASHIAN, MARIANA N · 2007 to 2011
$1.4M
NIA NIH HHS R01 AG019223NIA NIH HHS R01 AG026711
6 · The paper itself

Abstract

Evidence has consistently indicated that activation of sphingomyelinases and/or ceramide synthases and the resulting accumulation of ceramide mediate cellular responses to stressors such as lipopolysaccharide, interleukin 1beta, tumor necrosis factor alpha, serum deprivation, irradiation and various antitumor treatments. Recent studies had identified the genes encoding most of the enzymes responsible for the generation of ceramide and ongoing research is aimed at characterizing their individual functions in cellular response to stress. This chapter discusses the seminal and more recent discoveries in regards to the pathways responsible for the accumulation of ceramide during stress and the mechanisms by which ceramide affects cell functions. The former group includes the roles of neutral sphingomyelinase 2, serine palmitoyltransferase, ceramide synthases, as well as the secretory and endosomal/lysosomal forms of acid sphingomyelinase. The latter summarizes the mechanisms by which ceramide activate its direct targets, PKCzeta, PP2A and cathepsin D. The ability of ceramide to affect membrane organization is discussed in the light of its relevance to cell signaling. Emerging evidence to support the previously assumed notion that ceramide acts in a strictly structure-specific manner are also included. These findings are described in the context of several physiological and pathophysiological conditions, namely septic shock, obesity-induced insulin resistance, aging and apoptosis of tumor cells in response to radiation and chemotherapy.

Indexed as

Stress, PhysiologicalAnimalsApoptosisAutophagyBiophysical PhenomenaCeramidesHeat-Shock ResponseHumansInsulin ResistanceModels, BiologicalShock, SepticSphingomyelin PhosphodiesteraseCeramidesSphingomyelin Phosphodiesterase

Identifiers

PMID20919648
PMCPMC7122848
OpenAlexW129245961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.